브레인 피트니스 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the brain fitness market size is projected to be USD 9.55 billion in 2025, USD 10.48 billion in 2026, and reach USD 16.67 billion by 2031, growing at a CAGR of 9.73% from 2026 to 2031.

This report is Segmented by Offering (Brain Training Software and Mobile Applications, and More), Delivery (Mobile Applications, Web-Based Platforms, and More), Application (Preventive Cognitive Wellness, Cognitive Rehabilitation, and More), End User (Individual Consumers, Corporate Organizations, and More), and Geography (North America, Europe, Asia-Pacific, and More). Forecasts are Provided in Value (USD).

Global Brain Fitness Market Trends and Insights

Aging Population and Rising Cognitive-Health Awareness

The brain fitness market is increasingly supported by public health priorities linked to healthy aging and cognitive independence. The World Health Organization reports that the global population aged 60 years or older reached 1.1 billion in 2023 and is projected to reach 2.1 billion by 2050. Its July 2026 guidance identifies cognitive training and stimulation as preventive measures for adults with normal cognition or mild cognitive impairment. This guidance gives health systems, insurers, and public programs a clearer basis for considering structured cognitive programs. It also shifts procurement attention toward products that can show suitable evidence, reliable access, and appropriate support for older adults. In Japan and other aging economies, the brain fitness market has a stronger connection to care planning because cognitive decline affects health spending and long-term independence.

Increasing Prevalence of Dementia, ADHD, Stroke, and Traumatic Brain Injury

The growing burden of neurological and neurodevelopmental conditions creates demand for assessment, prevention, and rehabilitation tools. A 2025 study in Frontiers in Aging Neuroscience examined increasing dementia burden and substantial cross-country inequalities among adults aged 65 years or older. The study supports the need for scalable care pathways where specialist capacity remains limited. Cognitive platforms can help standardize measurement, guide follow-up, and support longitudinal monitoring when their use is clinically validated. The expansion of anti-amyloid treatment pathways further raises the need for consistent cognitive baselines before treatment decisions. The brain fitness market, therefore, has an opportunity in clinical workflows, but providers will expect evidence that digital results are reliable and meaningful for patient care.

Limited Transfer of App-Based Training Gains to Real-World Function

The main clinical constraint for the brain fitness market is the limited evidence that task improvement transfers to everyday functioning. A second-order meta-analysis covering 233 datasets found no far-transfer effect after accounting for placebo effects and publication bias. This distinction matters because payers and providers need evidence that a program improves meaningful outcomes, not only trained exercises. Companies seeking reimbursement must therefore conduct longer studies with functional outcomes, which raises cost and development time. Products built around driving simulation, occupational decisions, or activities of daily living may present a stronger case because their outcomes are closer to real-world demands. The brain fitness market will remain divided between general wellness products and clinical programs that can establish this broader value.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Digital Therapeutics and Remote Cognitive Care
2. AI-Personalized and Gamified Cognitive Training
3. Lengthy Clinical Validation and Regulatory Approval Timelines

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Brain training software and mobile applications held 52.31% of revenue in 2025. The segment benefits from broad consumer awareness, immediate digital access, and self-directed use across a wide range of age groups. Its scale also includes a wide variation in quality, from general wellness games to products developed for defined clinical needs. Lumos Labs received FDA clearance in December 2025 for its prescription digital therapy for adult ADHD, which shows how clinically focused software can move beyond consumer positioning. The reported trial results identified clinically meaningful attention gains in 44.2% of participants. Neurofeedback, virtual reality, and augmented reality products remain smaller revenue categories, yet they receive attention because they can support more immersive and measurable interventions. The brain fitness industry is moving toward clearer separation between products designed for casual use and platforms designed for clinical workflows. That separation is likely to influence procurement standards, trial design, and reimbursement discussions.

Brain training services and coaching are projected to grow at a 15.58% CAGR from 2026 to 2031. This pace reflects demand for structured facilitation where users need help with adherence, behavior change, and interpretation of results. GoMo Health launched Employee Resiliency, The Brain Studio, with the Center for BrainHealth in February 2026, combining behavioral science with brain health programming for employer settings. Guided programs can support corporate wellness clients and pharmaceutical research customers that require consistent protocols. Coaching also offers a route to improve long-term engagement, an area where self-guided applications often face limits. The brain fitness market size for coaching services is supported by the shift toward supported delivery rather than app access alone. Providers that can link coaching to validated content and measurable outcomes may have a more durable position in institutional accounts. This offering can also complement software platforms instead of replacing them.

Mobile applications held 64.24% of delivery-modality revenue in 2025. Smartphones provide the most familiar access point for individual users and enable frequent engagement outside clinics. This advantage also creates reliance on consumer devices that may limit the precision of certain clinical assessments. Web-based platforms remain useful for enterprise programs and trials that need browser access, cross-device consistency, and centrally managed security. Desktop and console systems retain a place in neuropsychology and research environments where detailed assessment tools are required. The brain fitness market continues to use mobile access as its main delivery route because it reduces barriers to routine participation. However, mobile providers must demonstrate that ease of access does not weaken data quality or clinical suitability. Delivery strategies increasingly combine mobile participation with clinician dashboards and structured follow-up.

Wearable and sensor-enabled platforms are forecast to grow at a 16.22% CAGR from 2026 to 2031. Their growth is tied to the ability to capture passive biometric information alongside active training activity. A 2025 study in Medical Engineering & Physics examined neural mechanisms of alpha-band EEG neurofeedback using portable devices. The 2026 ADHD study also showed that integrating a single-channel frontal EEG signal into a tablet game improved attention and cognitive control after 1 month. These results support the use of simpler hardware in appropriate neuroadaptive programs. The brain fitness market can benefit from sensors that improve personalization without creating an overly difficult setup for users. Companies that pair proprietary sensor capabilities with validated software may strengthen their intellectual property as hardware becomes more widely available. Privacy, consent, and clear data governance will remain essential because these platforms collect sensitive cognitive information.

Complete Report Scope:

• By Offering
  • Brain Training Software and Mobile Applications
  • Cognitive Assessment and Training Platforms
  • Brain Training Services and Coaching
  • Neurofeedback and Brain Training Tools
  • Virtual Reality and Augmented Reality Tools
  • Other Offerings
• By Delivery Modality
  • Mobile Applications
  • Web-Based Platforms
  • Desktop and Console-Based Platforms
  • Wearable and Sensor-Enabled Platforms
  • Other Delivery Modalities
• By Application
  • Preventive Cognitive Wellness
  • Cognitive Rehabilitation
  • Screening and Diagnostics
  • Clinical Trials and Pharmaceutical Research
  • Corporate Productivity and Employee Wellness
  • Other Applications
• By End User
  • Individual Consumers
  • Healthcare Providers and Clinics
  • Corporate Organizations
  • Senior Care Facilities
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 46.61% of global revenue in 2025. The region benefits from mature digital health infrastructure, health system purchasing capacity, and established regulatory pathways for clinical software. Multiple Medicare Advantage plans covered BrainHQ as a benefit in 2025, according to Posit Science. The region also has a large concentration of digital health investment and clinical research resources. These factors support product development and institutional adoption across the brain fitness market.

Asia-Pacific is forecast to grow at a 13.25% CAGR from 2026 to 2031. Japan's aging population supports insurer and employer interest in cognitive health services. NeU Corporation joined Asahi Life Insurance's Minna no Anshin 100 Year Project in March 2026 to provide cognitive brain training services to policyholders through smartphones and tablets. China has expanded the regulatory recognition of digital health products, according to the 2025 npj Digital Medicine review. Cambridge Cognition partnered with Ivory in February 2026 to deploy CANTAB Pathway across Indian healthcare and consumer health settings in 6 regional languages. India has a particular need for remote assessment because of limited specialist availability, making digital access relevant for both clinical and consumer use.

Europe, the Middle East and Africa, and South America accounted for the remaining revenue. Europe has concentrated neurology and neuropsychology capabilities in Germany, the United Kingdom, and France. Its medical device framework and social health insurance systems can support clinically validated digital rehabilitation. MindMaze enrolled the first patients in the SwissNeuroRehab study in July 2026 through the Neurorehab4EU consortium across Switzerland, France, and Italy. The Middle East and Africa remain at an earlier stage, while South America, led by Brazil, offers potential through expanding telemedicine infrastructure. Regional uptake will depend on local reimbursement, clinical capacity, language adaptation, reliable access to digital care, health system readiness, and adoption across care settings.

1. Advanced Brain Technologies
2. Akili
3. BRAINBOW LIMITED (Peak)
4. Brainwell
5. Cambridge Cognition Holdings plc
6. CNS Vital Signs, LLC
7. Cogmed
8. CogniFit Inc.
9. Cogstate Ltd
10. Constant Therapy Health, Inc.
11. Elevate Labs
12. HappyNeuron
13. Linus Health, Inc.
14. Lumos Labs, Inc.
15. MindMaze SA
16. Myndlift Ltd.
17. NeuroNation
18. NeuronUP S.L.
19. Neurotrack Technologies
20. Posit Science Corporation (BrainHQ)
21. SMARTfit Inc.
22. Synaptikon GmbH

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Aging Population and Rising Cognitive-Health Awareness
  • 4.2.2 Increasing Prevalence of Dementia, ADHD, Stroke, and Traumatic Brain Injury
  • 4.2.3 Expansion of Digital Therapeutics and Remote Cognitive Care
  • 4.2.4 AI-Personalized and Gamified Cognitive Training
  • 4.2.5 Cognitive Training Embedded in Education and Workplace Wellness
  • 4.2.6 Neuroadaptive Training Using Passive Biometrics and Wearables
• 4.3 Market Restraints
  • 4.3.1 Limited Transfer of App-Based Training Gains to Real-World Function
  • 4.3.2 Lengthy Clinical Validation and Regulatory Approval Timelines
  • 4.3.3 Privacy, Consent, and Secondary-Use Risks From Cognitive Data
  • 4.3.4 Low Long-Term Adherence After Initial User Acquisition
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Suppliers
  • 4.6.3 Bargaining Power of Buyers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Offering
  • 5.1.1 Brain Training Software and Mobile Applications
  • 5.1.2 Cognitive Assessment and Training Platforms
  • 5.1.3 Brain Training Services and Coaching
  • 5.1.4 Neurofeedback and Brain Training Tools
  • 5.1.5 Virtual Reality and Augmented Reality Tools
  • 5.1.6 Other Offerings
• 5.2 By Delivery Modality
  • 5.2.1 Mobile Applications
  • 5.2.2 Web-Based Platforms
  • 5.2.3 Desktop and Console-Based Platforms
  • 5.2.4 Wearable and Sensor-Enabled Platforms
  • 5.2.5 Other Delivery Modalities
• 5.3 By Application
  • 5.3.1 Preventive Cognitive Wellness
  • 5.3.2 Cognitive Rehabilitation
  • 5.3.3 Screening and Diagnostics
  • 5.3.4 Clinical Trials and Pharmaceutical Research
  • 5.3.5 Corporate Productivity and Employee Wellness
  • 5.3.6 Other Applications
• 5.4 By End User
  • 5.4.1 Individual Consumers
  • 5.4.2 Healthcare Providers and Clinics
  • 5.4.3 Corporate Organizations
  • 5.4.4 Senior Care Facilities
  • 5.4.5 Other End Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Advanced Brain Technologies
  • 6.3.2 Akili, Inc.
  • 6.3.3 BRAINBOW LIMITED (Peak)
  • 6.3.4 Brainwell
  • 6.3.5 Cambridge Cognition Holdings plc
  • 6.3.6 CNS Vital Signs, LLC
  • 6.3.7 Cogmed
  • 6.3.8 CogniFit Inc.
  • 6.3.9 Cogstate Ltd
  • 6.3.10 Constant Therapy Health, Inc.
  • 6.3.11 Elevate Labs
  • 6.3.12 HappyNeuron
  • 6.3.13 Linus Health, Inc.
  • 6.3.14 Lumos Labs, Inc.
  • 6.3.15 MindMaze SA
  • 6.3.16 Myndlift Ltd.
  • 6.3.17 NeuroNation
  • 6.3.18 NeuronUP S.L.
  • 6.3.19 Neurotrack Technologies, Inc.
  • 6.3.20 Posit Science Corporation (BrainHQ)
  • 6.3.21 SMARTfit Inc.
  • 6.3.22 Synaptikon GmbH

7 Market Opportunities and Future Outlook

• 7.1 White-Space and Unmet-Need Assessment